Folgen
Canberk Kayalar
Canberk Kayalar
Ph.D. Student
Bestätigte E-Mail-Adresse bei tamu.edu
Titel
Zitiert von
Zitiert von
Jahr
Very-rapidly dissolving printlets of isoniazid manufactured by SLS 3D printing: in vitro and in vivo characterization
T Khuroo, EM Mohamed, S Dharani, C Kayalar, T Ozkan, ...
Molecular pharmaceutics 19 (8), 2937-2949, 2022
132022
Preparation and characterization of 3D-printed dose-flexible printlets of tenofovir disoproxil fumarate
C Kayalar, Z Rahman, EM Mohamed, S Dharani, T Khuroo, N Helal, ...
AAPS PharmSciTech 24 (6), 171, 2023
12023
Pyrimethamine 3D printlets for pediatric toxoplasmosis: design, pharmacokinetics, and anti-toxoplasma activity
Z Rahman, T Khuroo, EM Mohamed, S Dharani, C Kayalar, ...
Expert Opinion on Drug Delivery 20 (2), 301-311, 2023
12023
In Vitro and In Vivo testing of 3D-Printed Amorphous Lopinavir Printlets by Selective Laser Sinitering: Improved Bioavailability of a Poorly Soluble Drug
C Kayalar, N Helal, EM Mohamed, S Dharani, T Khuroo, ...
AAPS PharmSciTech 25 (1), 20, 2024
2024
Current update and challenges of implementing 3D printing technologies in pharmaceutical manufacturing
Z Rahman, C Kayalar, NA Charoo, MTH Nutan, M Kuttolamadom, ...
From Current to Future Trends in Pharmaceutical Technology, 293-327, 2024
2024
Quality Control and Regulatory Landscape of 3D-Printed Drug Products
C Kayalar, NA Charoo, MTH Nutan, M Kuttolamadom, MA Khan, ...
3D Printing: Emerging Technologies and Functionality of Polymeric Excipients …, 2023
2023
Transduction of antigens into amplifiable DNA signals using structure switching aptamers
C Kayalar
Montana State University-Bozeman, College of Engineering, 2019
2019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–7